PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Title only   |   Print    Next page > 
     
2026 IMS | IASO Bio Presented First-in-Human Data of BCMA-Targeted In Vivo CAR-T Cell Therapy IASO206
— Late-breaking oral presentation of first-in-human data (LBA-11) showed that a single intravenous infusion of IASO206 generated functional BCMA CAR-T cells in vivo without lymphodepleting chemotherapy. ...
2026-09-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Second NRF2 Degrader Enters Clinical Development: Nutshell Therapeutics' NTS231 Received FDA IND Clearance
SHANGHAI , Sept. 25, 2026 /PRNewswire/ -- Nutshell Therapeutics (Shanghai) Co., Ltd. ("Nutshell Therapeutics"), an innovative biotech company focused on AI-driven allosteric drug discovery, ...
2026-09-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Lundbeck to establish global innovation hub in Greater Boston and relocate US headquarters
The new hub in Greater Boston will bring Lundbeck closer to one of the world's leading life sciences ecosystems, strengthening access to science, talent and partnerships. The move is part of Lundbeck's ...
2026-09-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Gene Solutions Study Finds Preterm-Birth Signals in Routine triSure NIPT Data
A Gene Solutions study published in American Journal of Obstetrics & Gynecology (AJOG) Global Reports finds cell-free DNA fragmentomic patterns associated with spontaneous preterm birth,  pointing ...
2026-09-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
XtalPi Submits U.S. FDA IND Application for KQTD-126, a Potential First-in-Class, Gut-Restricted Pan-TRK Inhibitor for Chronic Intestinal Pain
This milestone marks the first IND submission from XtalPi's proprietary pipeline, recently unveiled in its interim results, validating the company's AI and robotics-driven drug discovery platform and its ...
2026-09-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Basecamp Research raises $140M to advance AI-designed therapeutics
/C O R R E C T I O N -- Basecamp Research/ ...
2026-09-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Strategic Collaboration | Sanyou Bio and NovoCodex Partner to Co-Develop Innovative Dual-Payload ADCs
SHANGHAI and SHAOXING, China , Sept. 24, 2026 /PRNewswire/ -- Sanyou Biopharmaceuticals Co., Ltd. ("Sanyou Bio") and NovoCodex Biopharmaceuticals Co., Ltd. ("NovoCodex") jointly ...
2026-09-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
From diagnosis to treatment, ZEISS introduces innovations across ZEISS Retina Workflow at EURETINA 2026
ZEISS Medical Technology advances its  ZEISS Retina Workflow  with digital and surgical enhancements, and new imaging technologies, including: ...
2026-09-24T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Earendil Labs Announces Research Collaboration with Genentech to Discover and Develop Therapeutic Bispecific Antibodies in Oncology
WILMINGTON, Del. , Sept. 24, 2026 /PRNewswire/ -- Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research collaboration with Genentech, a member ...
2026-09-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Carestream Healthcare International Launches STARVIEW Digital Radiography System
SHANGHAI , Sept. 24, 2026 /PRNewswire/ -- Carestream Healthcare International announces the launch of the CARESTREAM STARVIEW Digital Radiography System , a focused, floor-mounted DR room designed ...
2026-09-24T    Computer Hardware   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.